drugset / Trial / NCT00267384
N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized, double-blind, placebo-controlled clinical trial will be performed to assess the effect of N-acetylcysteine therapy on the incidence of nephrotoxicity among patients hospitalized with an infection and treated with aminoglycosides (AGs). Secondary goals of the study will be as follows: comparison of the mortality rates, and length of hospitalization among patients treated with N-acetylcysteine compared to the control group.
Timeline
- Start
- 2006-03
- Primary completion
- 2008-05
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | — | Oral |
Indications
No indication recorded.